Gentioside



Compound IDCDAMM02658
Common nameGentioside
IUPAC name1-hydroxy-7-methoxy-3-[3,4,5-trihydroxy-6-[(3,4,5-trihydroxyoxan-2-yl)oxymethyl]oxan-2-yl]oxyxanthen-9-one
Molecular formulaC25H28O14

Experimental data

Retention time5.29
Adduct[M+H]+
Actual mz553.161
Theoretical mz553.155
Error11.07
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score7.3644

Identifiers and class information

Inchi keyDNIDCQUDANKQTL-LWAOGCTDNA-N
SmilesO=C1C2=CC(OC)=CC=C2OC3=CC(OC4OC(COC5OCC(O)C(O)C5O)C(O)C(O)C4O)=CC(O)=C13
SuperclassOrganoheterocyclic compounds
ClassBenzopyrans

Pharmacokinetic properties

Number of descriptor values(#stars)2
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)13
Number of reactive functional groups (#rtvFG)2
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)552.488
Computed dipole moment(dipole)2.553
Total solvent accessible surface area (SASA)756.963
Hydrophobic component of SASA (FOSA)298.77
Hydrophilic component of SASA (FISA)282.393
Pie component of the SASA (PISA)175.8
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1445.26
Number of hydrogen bond donors (donorHB)6
Number of hydrogen bond acceptors (accptHB)19.05
Free energy of solvation of dipole (dip^2/V)0.0045112
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0616447
Globularity descriptor (glob)0.816685
Predicted polarizability in cubic angstroms (QPpolrz)45.017
Predicted hexadecane/gas partition coefficient (QPlogPC16)16.205
Predicted octanol/gas partition coefficient (QPlogPoct)34.431
Predicted water/gas partition coefficient (QPlogPw)29.341
Predicted octanol/water partition coefficient (QPlogPo/w)-1.367
Predicted aqueous solubility (QPlogS)-2.223
Conformation-independent predicted aqueous solubility (CIQPlogS)-3.717
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-5.337
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)20.795
Predicted brain/blood partition coefficient (QPlogBB)-3.043
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)7.521
Predicted skin permeability, log Kp (QPlogKp)-4.857
PM3 calculated ionization potential (IP(ev))8.919
PM3 calculated electron affinity (EA(eV))0.634
Number of likely metabolic reactions (#metab)8
Prediction of binding to human serum albumin (QPlogKhsa)-1.269
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)3.656
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)216.959
Number of nitrogen and oxygen atoms (#NandO)14
Number of violations of Lipinski’s rule of five (RuleOfFive)3
Number of violations of Jorgensen’s rule of three (RuleOfThree)2

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
O43570CA12Carbonic anhydrase XIIT16987SEA
P43166CA7Carbonic anhydrase VIIT37541SEA
P22748CA4Carbonic anhydrase IVT53378SEA
P60568IL2Interleukin-2T61698SEA
Q9NUW8TDP1Tyrosyl-DNA phosphodiesterase 1T33492SEA
Q9UNQ0ABCG2ATP-binding cassette sub-family G member 2T56556SEA
P14679TYRTyrosinaseT97035SEA
Q9GZQ4NMUR2Neuromedin-U receptor 2T04210SEA
P47989XDHXanthine dehydrogenaseT40954SEA
Q16678CYP1B1Cytochrome P450 1B1T92521SEA
P16152CBR1Carbonyl reductase [NADPH] 1T70518SEA
Q9NZ08ERAP1Endoplasmic reticulum aminopeptidase 1T72849SEA
P30837ALDH1B1Acetaldehyde dehydrogenaseT99641SEA
Q9UK17KCND3Voltage-gated potassium channel Kv4.3T74500SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T16987DI0046Bacterial infection[ICD-11: 1A00-1C4Z]O43570CA12
T16987DI0372Seborrhoeic dermatitis[ICD-11: EA81]O43570CA12
T53378DI0046Bacterial infection[ICD-11: 1A00-1C4Z]P22748CA4
T53378DI0166Glaucoma[ICD-11: 9C61]P22748CA4
T53378DI0372Seborrhoeic dermatitis[ICD-11: EA81]P22748CA4
T61698DI0275Multiple sclerosis[ICD-11: 8A40]P60568IL2
T61698DI0361Renal cell carcinoma[ICD-11: 2C90]P60568IL2
T56556DI0218Irritable bowel syndrome[ICD-11: DD91]Q9UNQ0ABCG2
T56556DI0366Rheumatoid arthritis[ICD-11: FA20]Q9UNQ0ABCG2
T97035DI0007Acquired hypermelanosis[ICD-11: ED60]P14679TYR
T97035DI0008Acquired hypomelanotic disorder[ICD-11: ED63]P14679TYR
T40954DI0206Inborn purine/pyrimidine/nucleotide metabolism error[ICD-11: 5C55]P47989XDH
T40954DI0266Mineral deficiency[ICD-11: 5B5K]P47989XDH
T70518DI0037Asthma[ICD-11: CA23]P16152CBR1
T99641DI0396Substance abuse[ICD-11: 6C40]P30837ALDH1B1
T74500DI0004Acidosis[ICD-11: 5C73]Q9UK17KCND3

Copyright © 2025